|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
14,310,000 |
Market
Cap: |
9.45(M) |
Last
Volume: |
26,960 |
Avg
Vol: |
26,885 |
52
Week Range: |
$0.5651 - $1.28 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for rare and life-threatening diseases. Co.'s pipeline includes four programs: ACER-001 (sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; ACER-801 (osanetant) for the treatment of induced vasomotor symptoms; EDSIVO (celiprolol) for the treatment of vascular Ehlers-Danlos syndrome in patients with a confirmed type III collagen mutation; and ACER-2820 (emetine), a host-directed therapy against a variety of viruses, including cytomegalovirus, zika, dengue, ebola and COVID-19.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,229,508 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,500,000 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Schelling Chris |
President and CEO |
|
2017-09-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,750,000 |
1,750,000 |
|
- |
|
Barabe Timothy C |
Director |
|
2016-11-18 |
4 |
S |
$0.55 |
$8,210 |
D/D |
(14,914) |
12,910 |
|
- |
|
Maderis Gail J |
Director |
|
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
25,884 |
|
- |
|
Seaman Scott B |
Director |
|
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
29,989 |
|
- |
|
Richman Michael |
Director |
|
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
25,884 |
|
- |
|
Barabe Timothy C |
Director |
|
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
27,824 |
|
- |
|
Maderis Gail J |
Director |
|
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
19,429 |
|
- |
|
Barabe Timothy C |
Director |
|
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
21,369 |
|
- |
|
Seaman Scott B |
Director |
|
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
23,534 |
|
- |
|
Richman Michael |
Director |
|
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
19,429 |
|
- |
|
Seaman Scott B |
Director |
|
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
17,079 |
|
- |
|
Richman Michael |
Director |
|
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
12,974 |
|
- |
|
Maderis Gail J |
Director |
|
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
12,974 |
|
- |
|
Barabe Timothy C |
Director |
|
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,455 |
14,914 |
|
- |
|
Barabe Timothy C |
Director |
|
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,354 |
8,460 |
|
- |
|
Richman Michael |
Director |
|
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,354 |
6,520 |
|
- |
|
Maderis Gail J |
Director |
|
2015-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,354 |
6,520 |
|
- |
|
Healey Don |
Chief Scientific OfficerOffice |
|
2015-10-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,045 |
|
- |
|
Barabe Timothy C |
Director |
|
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,200 |
7,106 |
|
- |
|
Maderis Gail J |
Director |
|
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,200 |
5,166 |
|
- |
|
Richman Michael |
Director |
|
2015-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,200 |
5,166 |
|
- |
|
Richman Michael |
Director |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,427 |
31,729 |
|
- |
|
Maderis Gail J |
Director |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,427 |
31,729 |
|
- |
|
Barabe Timothy C |
Director |
|
2015-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,427 |
47,245 |
|
- |
|
Warma Neil K |
President and CEO |
|
2015-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,247 |
144,881 |
|
- |
|
170 Records found
|
|
Page 2 of 7 |
|
|